Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... This phase II trial studies how well donor peripheral blood stem cell (PBSC) transplant works in treating patients with hematologic ... who may benefit from tandem autologous-nonmyeloablative allogeneic transplant Left ventricular ejection fraction at rest must be >= ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.

  2. Pasireotide in Prevention of GI Toxicity

    ... side effects of the drugs received to prepare for allogeneic stem cell transplant . The study will also evaluate if Pasireotide is ...

    Clinical Trial last updated 06/06/2016 - 10:41am.

  3. Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

    ... of improvement (relapsed) undergoing a second donor stem cell transplant . IMTMI is a type of radiation therapy to the bone ... high risk myelodysplastic syndrome (MDS) undergoing second allogeneic (allo)- stem cell transplant (SCT) using the same donor or ...

    Clinical Trial last updated 05/23/2016 - 2:06pm.

  4. Graft-vs-host-disease (GVHD): Signs, Symptoms, and Treatment

    ... An allogeneic stem cell transplant uses blood-forming cells ( stem cells ) donated ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  5. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... plus a CD34+ selected T-cell depleted peripheral blood stem cell (PBSC) stem cell transplant for the treatment of patients ... or acute myelogenous leukemia for whom an allogeneic stem cell transplant is indicated. ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  6. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... this study is to find out whether the addition of blood stem cells from a close family member, when added to two units of umbilical ... FACT-approved SOP for "DONOR EVALUATION AND SELECTION FOR ALLOGENEIC TRANSPLANTATION" in the Blood and Marrow Transplant Program Manual, ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  7. Clone of Patients

    Learn About Your Disease Once the initial shock of a bone marrow failure diagnosis wears off, the best thing to do is lea...

    Page last updated 03/14/2016 - 6:05pm.

  8. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... improved in the group of patients who receive a T-cell replete haploidentical donor hematopoietic cell transplant (HCT) with a ... that have relapsed or are refractory after prior allogeneic transplant. Toxicity will be evaluated by the rate of transplant ... clofarabine Given on Day -9 and Day -8 (Day 0 is first stem cell infusion). Drug class: antineoplastic agent Other ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  9. Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC (ExpMACs)

    ... ) matched sibling donor and who are candidates for allogeneic hematopoietic stem cell transplant (HSCT). These patients have a serious or immediately ...

    Clinical Trial last updated 06/13/2016 - 1:47pm.

  10. Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    ... and immune system often benefit from transplants of stem cells from a genetically well-matched sibling. However, severe ... of high-dose preparative chemotherapy, this study performs allogeneic transplant after low doses of chemotherapy. In an attempt to improve ...

    Clinical Trial last updated 04/28/2016 - 11:28am.